
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-07-01-2015
- Volume 11
- Issue 7
FDA Fights Online Counterfeit Drugs
The agency takes action against websites that illegally sell unapproved medications.
FDA announced on June 18, 2015 that the agency and international law enforcement agencies have taken action against websites that sell unapproved prescription drugs and medical devices to consumers. FDA has issued regulatory warnings and seized illegal medicines and medical devices worldwide during Operation Pangea VIII, part of the INTERPOL-led Eighth Annual International Internet Week of Action (IIWA). IIWA is an international cooperative effort to combat counterfeit drugs sold on the Internet that includes 111 participating countries and several law enforcement agencies.
Nearly 400 websites that offer unapproved or misbranded drugs to US patients received FDA Warning Letters. Illegal drug products were seized from International Mail Facilities in Chicago, Miami, and New York, with 814 packages detained and referred to FDA. Drugs seized included unapproved antidepressants, hormone replacement therapies, sleep aids, erectile dysfunction treatments, and high cholesterol medications.
“Our efforts to protect the health of American patients by preventing the online sale of potentially dangerous illegal medical products will not cease,” said George Karavetsos, director of the FDA’s Office of Criminal Investigations, in a
Source:
Articles in this issue
over 10 years ago
SGS Completes New Labs at Shanghai Facilityover 10 years ago
American Airlines Cargo Opens Philadelphia Facilityover 10 years ago
Assay Testing Shifts to Outsourced Operationsover 10 years ago
New Ways Around Hazardous Reagent Chemistryover 10 years ago
Making Manufacturing Modernization Easierover 10 years ago
GS1 US Appoints Greg Bylo Vice-President of Healthcareover 10 years ago
EMVO Names Service Providers for FMD Projectover 10 years ago
Novasep Plans ADC Facility in Franceover 10 years ago
Pharmacy Associations Ask FDA to Delay Track-and-Trace RequirementsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.




